Peak V'O2 is an independent predictor of survival in patients with cardiac amyloidosis.

Selina HeinFabian Aus Dem SiepenRalf BauerHugo A KatusArnt V Kristen

Published in: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2018)

We identified reduced peak V'O2 as an independent predictor of mortality in patients with cardiac involvement in different forms of systemic amyloidosis.

Keyphrases

left ventricular
multiple myeloma
cardiovascular events
risk factors
type diabetes
heart failure
cardiovascular disease
atrial fibrillation